TUSC2 (Tumor Suppressor Candidate 2, C3orf11, FUS1, Fus-1 Protein, Fusion 1 Protein, LGCC, PAP, PDAP2, PDGFA-associated Protein 2, Tumor Suppressor Candidate 2) (Control Peptide)[TUSC2]

General information
 

Name:
TUSC2 (Tumor Suppressor Candidate 2, C3orf11, FUS1, Fus-1 Protein, Fusion 1 Protein, LGCC, PAP, PDAP2, PDGFA-associated Protein 2, Tumor Suppressor Candidate 2) (Control Peptide)[TUSC2]
Size:
NA
Catalog no:
MBS659763
Price:
5 EUR
 

Additional extra details
 

  • Products_type

    Peptide

    Tissue

    control, tumor

    Description

    Isotype or positive controls by peptides, antibodies and deactivated samples.Fusion proteins or chimeric proteins are proteins created through the joining of two or more genes that originally coded for separate proteins. A GFP gene is often used as tag to a reporter gene. Fusion lentiverctors can be used as viral particles to produce proteins that carry for example a GFP tag. Antigen purification of recombinant fusion tag proteins is a frequent strategy using a Fralg tag.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.Kinase, breast cancer tumor, HRAS like - suppressor protein make genetic suppression restoring the phenotype seen prior to the original background in biological pathways.